[ Price : $8.95]
Researchers are using a National Science Foundation grant to determine whether social media postings can be used as an adverse dru...[ Price : $8.95]
Reps. Bilbray, Maloney, and DeLauro introduce legislation to provide additional exclusivity for drugs designated by FDA as signifi...[ Price : $8.95]
Federal Register Final rule: FDA amends the animal drug regulations to withdraw approval of one NADA and three ANADAs because they...[ Price : $8.95]
Federal Register Notice: CDER will co-sponsor a training course 11/13-15 for clinical investigators in College Park, MD.[ Price : $8.95]
A OneKey analysis of healthcare practitioner use of social media finds that oncologists are more active in social media than other...[ Price : $8.95]
Celltex Therapeutics says it will appeal a recent FDA decision that the process it uses to multiply adult stem cells is subject to...[ Price : $8.95]
An FDA-commissioned bioequivalence study of Tevas Budeprion XL 300mg ends six years of controversy over adverse effects in patient...[ Price : $8.95]
A new study says that pediatric drug exclusivity strategies can see a return-on-investment on average of $130 for every $1 spent.